Psychiatry Research
Volume 120, Issue 3 , Pages 231-238 , 15 October 2003

Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy

  • Peter Schönknecht

      Affiliations

    • Department of Psychiatry, Section of Geriatric Psychiatry, University of Heidelberg, Voss-Street 4, Heidelberg D-69115, Germany
    • ,
  • Johannes Pantel

      Affiliations

    • Department of Psychiatry, Section of Geriatric Psychiatry, University of Heidelberg, Voss-Street 4, Heidelberg D-69115, Germany
    • ,
  • Tobias Hartmann

      Affiliations

    • Center for Molecular Biology Heidelberg (ZMBH), University of Heidelberg, Heidelberg, Germany
    • ,
  • Egon Werle

      Affiliations

    • Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
    • ,
  • Martin Volkmann

      Affiliations

    • Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
    • ,
  • Marco Essig

      Affiliations

    • German Cancer Research Center (DKFZ), Heidelberg, Germany
    • ,
  • Michael Amann

      Affiliations

    • German Cancer Research Center (DKFZ), Heidelberg, Germany
    • ,
  • Nadja Zanabili

      Affiliations

    • Department of Psychiatry, Section of Geriatric Psychiatry, University of Heidelberg, Voss-Street 4, Heidelberg D-69115, Germany
    • ,
  • Hubertus Bardenheuer

      Affiliations

    • Department of Experimental Anesthesia, University of Heidelberg, Heidelberg, Germany
    • ,
  • Aoife Hunt

      Affiliations

    • Department of Psychiatry, Section of Geriatric Psychiatry, University of Heidelberg, Voss-Street 4, Heidelberg D-69115, Germany
    • ,
  • Johannes Schröder

      Affiliations

    • Department of Psychiatry, Section of Geriatric Psychiatry, University of Heidelberg, Voss-Street 4, Heidelberg D-69115, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-6221-564403; fax: +49-6221-565327

Received 21 May 2001 ,Revised 12 December 2001 ,Accepted 18 January 2002.

References 

  1. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., revised. Washington, DC: Author; 1987;
  2. Andreasen N, Vanmechelen E, Van de Voorde A, Davidsson P, Hesse C, Tarvonen S, et al. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community follow up study. Journal of Neurology, Neurosurgery and Psychiatry. 1998;64:298–305
  3. Andreasen N, Minthon L, Clarberg A, Davidsson P, Gottfries J, Vanmechelen E, et al. Sensitivity, specificity, and stability of CSF-tau in AD in a community based patient sample. Neurology. 1999;53:1488–1494
  4. Arai H, Terajima M, Miura M, Higuchi S, Muramatsu T, Machida N, et al. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Annals of Neurology. 1995;38:649–652
  5. Arai H, Satoh-Nakagawa T, Higuchi M, Morikawa Y, Miura M, Kawakami H, et al. No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia. Neuroscience Letters. 1998;256:174–176
  6. Blennow K, Wallin A, Ågren H, Spenger C, Siegfried J, Vanmechelen E. Tau protein in cerebrospinal fluid—a biochemical marker for axonal degeneration in Alzheimer disease?. Molecular and Chemical Neuropathology. 1995;26:231–245
  7. Buch K, Riemenschneider M, Bartenstein P, Willoch F, Müller U, Schmolke M, et al. Tau–Protein–Ein potentieller biologischer Indikator zur Früherkennung der Alzheimer—Krankheit. Nervenarzt. 1998;69:379–385
  8. Folstein MF, Folstein SE, McHugh PR. ‘Mini Mental State’. A practical method for grading the cognitive state of patients for the clinicians. Journal of Psychiatric Research. 1975;12:189–198
  9. Galasko D, Chang L, Motter R, Clark CM, Kaye J, Koopman D, et al. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer's disease and relation to apolipoprotein E genotype. Archives of Neurology. 1998;5:937–945
  10. Golombowski S, Müller-Spahn F, Romig H, Mendla K, Hock C. Dependence of cerebrospinal fluid tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease. Neuroscience Letters. 1997;225:213–215
  11. Green AJ, Harvey RJ, Thompson EJ, Rossor MN. Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease. Neuroscience Letters. 1999;259:133–135
  12. Hesse C, Rosengren L, Andreasen N, Davidsson P, Vanderstichele H, Vanmechelen E, et al. Transient increase in total tau but not phospho—tau in human cerebrospinal fluid after acute stroke. Neuroscience Letters. 2001;197:187–190
  13. Hock C, Golombowski S, Naser W, Müller-Spahn F. Increased levels of J protein in cerebrospinal fluid of patients with Alzheimer's disease—correlation with degree of cognitive impairment. Annals of Neurology. 1995;37:414–415
  14. Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP, et al. Improved discrimination of AD patients using β-amyloid(1–42) and tau levels in CSF. Neurology. 1999;52:1555–1562
  15. Jellinger KA. Diagnostic accuracy of Alzheimer's disease: a clinicopathological study. Acta Neuropathologica. 1996;91:219–220
  16. Jensen M, Basun H, Lannfelt L. Increased cerebrospinal fluid tau in patients with Alzheimer's disease. Neuroscience Letters. 1995;186:189–191
  17. Kahle PJ, Jakowec M, Teipel SJ, Hampel H, Petzinger GM, DiMonte DA, et al. Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF. Neurology. 2000;54:1498–1504
  18. Kanai M, Matsubara E, Isoe K, Urakami K, Nakashima K, Arai H, et al. Longitudinal study of cerebrospinal fluid levels of tau, Aβ 1–40, and Aβ 1–42(43) in Alzheimer's disease: a study in Japan. Annals of Neurology. 1998;44:17–26
  19. Kosunen O, Soininen H, Paljrvi L, Heinonen O, Talasniemi S, Riekkinen PJ. Diagnostic accuracy of Alzheimer's disease: a neuropathological study. Acta Neuropathologica. 1996;91:185–193
  20. Loeb C, Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia. Stroke. 1983;14:399–401
  21. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–965
  22. Mecocci P, Cherubini A, Bregnocchi M, Chionne F, Cecchetti R, Lowenthal DT, et al. Tau protein in cerebrospinal fluid: a new diagnostic and prognostic marker in Alzheimer disease?. Alzheimer Disease and Associated Disorders. 1998;12:211–214
  23. Mori H, Hosoda K, Matsubara E, Nakamoto T, Furiya Y, Endoh R, et al. Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequences in tau. Neuroscience Letters. 1995;186:181–183
  24. Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, et al. Reduction of β-amyloid-peptide 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Annals of Neurology. 1995;38:643–648
  25. Munroe W, Southwick PC, Chang L, Scharre DW, Echols CL, Fu PC, et al. Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease. Annals of Clinical and Laboratory Science. 1995;25:207–217
  26. Nishimura T, Takeda M, Nakamura Y, Yosbida Y, Arai H, Sasaki H, et al. Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan. Methods and Findings in Experimental and Clinical Pharmacology. 1998;20:227–235
  27. Pantel J, Schröder J, Schad LR, Friedlinger M, Knopp MV, Schmitt R, et al. Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type. Psychological Medicine. 1997;27:221–229
  28. Pantel J, Schröder J, Essig M, Schneider G, Eysenbach K, von Kummer R, et al. In vivo quantification of brain volumes in subcortical vascular dementia and Alzheimer's disease—a MRI based study. Dementia and Geriatrric Cognitive Disorders. 1998;9:309–316
  29. Riemenschneider M, Buch K, Schmolke M, Kurz A, Guder WG. Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase. Lancet. 1997;350:784
  30. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250–260
  31. Schröder J, Pantel J. Morphologische und funktionelle Bildgebung. In:  Förstl H editors. Alzheimer Demenz. Berlin–Heidelberg–New York: Springer; 1999;
  32. Schröder J, Pantel J, Ida N, Essig M, Hartmann T, Knopp MV, et al. Cerebral changes and cerebrospinal fluid β-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging. Molecular Psychiatry. 1997;2:505–507
  33. Shoji M, Matsubara E, Kanai M, Watanabe M, Nakamura T, Tomidokoro Y, et al. Combination assay of CSF tau, A beta 1–40 and A beta 1–42 (43) as a biochemical marker of Alzheimer's disease. Journal of the Neurological Sciences. 1998;158:134–140
  34. Skoog I, Vanmechelen E, Andreasson LA, Palmertz B, Davidsson P, Hesse C, et al. A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele. Neurodegeneration. 1995;4:433–442
  35. Sunderland T, Wolozin B, Galasko D, Levy J, Dukoff R, Bahro M, et al. Longitudinal stability of CSF tau levels in Alzheimer's patients. Biological Psychiatry. 1999;46:750–755
  36. Tapiola T, Pirttil T, Mikkonen M, Mehta PD, Alafuzoff I, Koivisto K, et al. Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's disease. Neuroscience Letters. 2000;280:119–122
  37. Tapiola T, Lethovirta M, Ramberg J, Helisalmi S, Linnaranta K, Riekkinen P, et al. CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease. Neurology. 1998;50:169–174
  38. Tato R, Frank A, Hernanz A. Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type. Journal of Neurology, Neurosurgery and Psychiatry. 1995;59:280–283
  39. Vandermeeren M, Mercken M, Vanmechelen E, Six J, van de Voorde A, Martin JJ, et al. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. Journal of Neurochemistry. 1993;61:1828–1834
  40. Vigo-Pelfrey C, Seubert P, Barbour R, Blomquist C, Lee M, Lee D, et al. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease. Neurology. 1995;45:788–793

PII: S0165-1781(03)00197-5

doi: 10.1016/S0165-1781(03)00197-5

Psychiatry Research
Volume 120, Issue 3 , Pages 231-238 , 15 October 2003

Article Tools

* Image Usage & Resolution